Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
Identifieur interne : 000C92 ( PubMed/Checkpoint ); précédent : 000C91; suivant : 000C93Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
Auteurs : Jean-Christophe Corvol [France] ; Jean-Baptiste Anzouan-Kacou ; Elodie Fauveau ; Anne-Marie Bonnet ; Bénédicte Lebrun-Vignes ; Camille Girault ; Yves Agid [France] ; Philippe Lechat ; Richard Isnard ; Lucette LacomblezSource :
- Archives of neurology [ 0003-9942 ] ; 2007.
English descriptors
- KwdEn :
- Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Aortic Valve Insufficiency (chemically induced), Aortic Valve Insufficiency (epidemiology), Dose-Response Relationship, Drug, Echocardiography, Female, Heart Valve Diseases (chemically induced), Heart Valve Diseases (epidemiology), Humans, Logistic Models, Male, Middle Aged, Mitral Valve Insufficiency (chemically induced), Mitral Valve Insufficiency (epidemiology), Odds Ratio, Parkinson Disease (complications), Parkinson Disease (drug therapy), Pergolide (adverse effects), Pergolide (therapeutic use), Prospective Studies, Risk Factors, Tricuspid Valve Insufficiency (chemically induced), Tricuspid Valve Insufficiency (epidemiology).
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Pergolide.
- chemical , therapeutic use : Antiparkinson Agents, Pergolide.
- chemically induced : Aortic Valve Insufficiency, Heart Valve Diseases, Mitral Valve Insufficiency, Tricuspid Valve Insufficiency.
- complications : Parkinson Disease.
- drug therapy : Parkinson Disease.
- epidemiology : Aortic Valve Insufficiency, Heart Valve Diseases, Mitral Valve Insufficiency, Tricuspid Valve Insufficiency.
- Dose-Response Relationship, Drug, Echocardiography, Female, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Prospective Studies, Risk Factors.
Abstract
To investigate the prevalence and risk factors of heart valve disease in patients having PD treated with pergolide.
DOI: 10.1001/archneur.64.12.1721
PubMed: 18071034
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:18071034Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.</title><author><name sortKey="Corvol, Jean Christophe" sort="Corvol, Jean Christophe" uniqKey="Corvol J" first="Jean-Christophe" last="Corvol">Jean-Christophe Corvol</name><affiliation wicri:level="3"><nlm:affiliation>Service de Pharmacologie, Hôpital de la Pitié-Salpêtrière, 45/83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France. jean-christophe.corvol@psl.aphp.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Pharmacologie, Hôpital de la Pitié-Salpêtrière, 45/83 Boulevard de l'Hôpital, 75651, Paris Cedex 13</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Anzouan Kacou, Jean Baptiste" sort="Anzouan Kacou, Jean Baptiste" uniqKey="Anzouan Kacou J" first="Jean-Baptiste" last="Anzouan-Kacou">Jean-Baptiste Anzouan-Kacou</name></author><author><name sortKey="Fauveau, Elodie" sort="Fauveau, Elodie" uniqKey="Fauveau E" first="Elodie" last="Fauveau">Elodie Fauveau</name></author><author><name sortKey="Bonnet, Anne Marie" sort="Bonnet, Anne Marie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name></author><author><name sortKey="Lebrun Vignes, Benedicte" sort="Lebrun Vignes, Benedicte" uniqKey="Lebrun Vignes B" first="Bénédicte" last="Lebrun-Vignes">Bénédicte Lebrun-Vignes</name></author><author><name sortKey="Girault, Camille" sort="Girault, Camille" uniqKey="Girault C" first="Camille" last="Girault">Camille Girault</name></author><author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name><affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName><country>France</country><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author><author><name sortKey="Lechat, Philippe" sort="Lechat, Philippe" uniqKey="Lechat P" first="Philippe" last="Lechat">Philippe Lechat</name></author><author><name sortKey="Isnard, Richard" sort="Isnard, Richard" uniqKey="Isnard R" first="Richard" last="Isnard">Richard Isnard</name></author><author><name sortKey="Lacomblez, Lucette" sort="Lacomblez, Lucette" uniqKey="Lacomblez L" first="Lucette" last="Lacomblez">Lucette Lacomblez</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:18071034</idno><idno type="pmid">18071034</idno><idno type="doi">10.1001/archneur.64.12.1721</idno><idno type="wicri:Area/PubMed/Corpus">000D34</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D34</idno><idno type="wicri:Area/PubMed/Curation">000C94</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C94</idno><idno type="wicri:Area/PubMed/Checkpoint">000C94</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C94</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.</title><author><name sortKey="Corvol, Jean Christophe" sort="Corvol, Jean Christophe" uniqKey="Corvol J" first="Jean-Christophe" last="Corvol">Jean-Christophe Corvol</name><affiliation wicri:level="3"><nlm:affiliation>Service de Pharmacologie, Hôpital de la Pitié-Salpêtrière, 45/83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France. jean-christophe.corvol@psl.aphp.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Pharmacologie, Hôpital de la Pitié-Salpêtrière, 45/83 Boulevard de l'Hôpital, 75651, Paris Cedex 13</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Anzouan Kacou, Jean Baptiste" sort="Anzouan Kacou, Jean Baptiste" uniqKey="Anzouan Kacou J" first="Jean-Baptiste" last="Anzouan-Kacou">Jean-Baptiste Anzouan-Kacou</name></author><author><name sortKey="Fauveau, Elodie" sort="Fauveau, Elodie" uniqKey="Fauveau E" first="Elodie" last="Fauveau">Elodie Fauveau</name></author><author><name sortKey="Bonnet, Anne Marie" sort="Bonnet, Anne Marie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name></author><author><name sortKey="Lebrun Vignes, Benedicte" sort="Lebrun Vignes, Benedicte" uniqKey="Lebrun Vignes B" first="Bénédicte" last="Lebrun-Vignes">Bénédicte Lebrun-Vignes</name></author><author><name sortKey="Girault, Camille" sort="Girault, Camille" uniqKey="Girault C" first="Camille" last="Girault">Camille Girault</name></author><author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name><affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName><country>France</country><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author><author><name sortKey="Lechat, Philippe" sort="Lechat, Philippe" uniqKey="Lechat P" first="Philippe" last="Lechat">Philippe Lechat</name></author><author><name sortKey="Isnard, Richard" sort="Isnard, Richard" uniqKey="Isnard R" first="Richard" last="Isnard">Richard Isnard</name></author><author><name sortKey="Lacomblez, Lucette" sort="Lacomblez, Lucette" uniqKey="Lacomblez L" first="Lucette" last="Lacomblez">Lucette Lacomblez</name></author></analytic><series><title level="j">Archives of neurology</title><idno type="ISSN">0003-9942</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Aortic Valve Insufficiency (chemically induced)</term><term>Aortic Valve Insufficiency (epidemiology)</term><term>Dose-Response Relationship, Drug</term><term>Echocardiography</term><term>Female</term><term>Heart Valve Diseases (chemically induced)</term><term>Heart Valve Diseases (epidemiology)</term><term>Humans</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Mitral Valve Insufficiency (chemically induced)</term><term>Mitral Valve Insufficiency (epidemiology)</term><term>Odds Ratio</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Pergolide (adverse effects)</term><term>Pergolide (therapeutic use)</term><term>Prospective Studies</term><term>Risk Factors</term><term>Tricuspid Valve Insufficiency (chemically induced)</term><term>Tricuspid Valve Insufficiency (epidemiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Pergolide</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Pergolide</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Aortic Valve Insufficiency</term><term>Heart Valve Diseases</term><term>Mitral Valve Insufficiency</term><term>Tricuspid Valve Insufficiency</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Aortic Valve Insufficiency</term><term>Heart Valve Diseases</term><term>Mitral Valve Insufficiency</term><term>Tricuspid Valve Insufficiency</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Dose-Response Relationship, Drug</term><term>Echocardiography</term><term>Female</term><term>Humans</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Odds Ratio</term><term>Prospective Studies</term><term>Risk Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To investigate the prevalence and risk factors of heart valve disease in patients having PD treated with pergolide.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18071034</PMID><DateCreated><Year>2007</Year><Month>12</Month><Day>11</Day></DateCreated><DateCompleted><Year>2008</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9942</ISSN><JournalIssue CitedMedium="Print"><Volume>64</Volume><Issue>12</Issue><PubDate><Year>2007</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch. Neurol.</ISOAbbreviation></Journal><ArticleTitle>Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>1721-6</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the prevalence and risk factors of heart valve disease in patients having PD treated with pergolide.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective observational study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Patients were recruited at the Hôpital de la Pitié-Salpêtrière, Paris, France. Patients Ninety-six patients having PD treated with pergolide for longer than 3 months vs 50 control subjects. Intervention Standardized echocardiography performed by an investigator blinded to treatment status. Main Outcome Measure Moderate to severe regurgitation in at least 1 heart valve.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred thirty-three echocardiograms (86 in the pergolide-treated group and 47 in the control group) were analyzed in the study. Moderate to severe regurgitation was found in 15 patients treated with pergolide (17.4%) and in 2 control subjects (4.3%) (odds ratio [OR], 4.75; 95% confidence interval [CI], 1.02-22.1; P = .03). Moderate to severe regurgitation was associated with the cumulative dose of pergolide (OR, 1.37; 95% CI, 1.04-1.81 per 10-mg/kg increase; P =.03). Including the present study, the meta-analysis comprised 7 trials (394 patients treated with pergolide and 280 controls). The overall OR for moderate to severe regurgitation was 3.1 (95% CI, 1.7-5.6; P < .001) in the pergolide-treated group. Risk differences were correlated with the mean cumulative dose of pergolide (r = 0.90, P < .001).</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Using an end point of moderate to severe heart valve regurgitation, we performed a meta-analysis of patients having Parkinson disease (PD) treated with pergolide mesylate vs control subjects by searching PubMed (January 1, 1966, to April 1, 2007) and the Cochrane databases to identify English-language prospective observational studies that reported echocardiographic data.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Heart valve disease is independently associated with the use of pergolide treatment in patients having PD and correlates with its cumulative dose. Trial Registration clinicaltrials.gov Identifier: NCT00202657.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corvol</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Service de Pharmacologie, Hôpital de la Pitié-Salpêtrière, 45/83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France. jean-christophe.corvol@psl.aphp.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anzouan-Kacou</LastName><ForeName>Jean-Baptiste</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Fauveau</LastName><ForeName>Elodie</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bonnet</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Lebrun-Vignes</LastName><ForeName>Bénédicte</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Girault</LastName><ForeName>Camille</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Agid</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Lechat</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Isnard</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Lacomblez</LastName><ForeName>Lucette</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00202657</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>24MJ822NZ9</RegistryNumber><NameOfSubstance UI="D010479">Pergolide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001022" MajorTopicYN="N">Aortic Valve Insufficiency</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006349" MajorTopicYN="N">Heart Valve Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008944" MajorTopicYN="N">Mitral Valve Insufficiency</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010479" MajorTopicYN="N">Pergolide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014262" MajorTopicYN="N">Tricuspid Valve Insufficiency</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>25</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>12</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>1</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>12</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18071034</ArticleId><ArticleId IdType="pii">64/12/1721</ArticleId><ArticleId IdType="doi">10.1001/archneur.64.12.1721</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement><orgName><li>Hôpital de la Salpêtrière</li></orgName></list><tree><noCountry><name sortKey="Anzouan Kacou, Jean Baptiste" sort="Anzouan Kacou, Jean Baptiste" uniqKey="Anzouan Kacou J" first="Jean-Baptiste" last="Anzouan-Kacou">Jean-Baptiste Anzouan-Kacou</name><name sortKey="Bonnet, Anne Marie" sort="Bonnet, Anne Marie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name><name sortKey="Fauveau, Elodie" sort="Fauveau, Elodie" uniqKey="Fauveau E" first="Elodie" last="Fauveau">Elodie Fauveau</name><name sortKey="Girault, Camille" sort="Girault, Camille" uniqKey="Girault C" first="Camille" last="Girault">Camille Girault</name><name sortKey="Isnard, Richard" sort="Isnard, Richard" uniqKey="Isnard R" first="Richard" last="Isnard">Richard Isnard</name><name sortKey="Lacomblez, Lucette" sort="Lacomblez, Lucette" uniqKey="Lacomblez L" first="Lucette" last="Lacomblez">Lucette Lacomblez</name><name sortKey="Lebrun Vignes, Benedicte" sort="Lebrun Vignes, Benedicte" uniqKey="Lebrun Vignes B" first="Bénédicte" last="Lebrun-Vignes">Bénédicte Lebrun-Vignes</name><name sortKey="Lechat, Philippe" sort="Lechat, Philippe" uniqKey="Lechat P" first="Philippe" last="Lechat">Philippe Lechat</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Corvol, Jean Christophe" sort="Corvol, Jean Christophe" uniqKey="Corvol J" first="Jean-Christophe" last="Corvol">Jean-Christophe Corvol</name></region><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C92 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000C92 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:18071034
|texte= Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:18071034" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |